Test Price
2,800 AED✅ Home Collection Available
WASHC5 Gene (SPG8) Genetic Test (NGS) in Dubai, UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM – 11 PM).
- Clinical Guidance: Complimentary Telephonic Post‑Test Result Interpretation by a Consultant Medical Geneticist.
- Insurance: Direct Billing Verification & Pre‑approval via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
This advanced NGS‑based test analyzes the entire coding sequence of the WASHC5 gene to diagnose or confirm Hereditary Spastic Paraplegia type 8 (SPG8), a progressive neurological disorder. The test is performed at a DHA‑licensed facility (License No. 1143) under strict ISO‑certified logistics, with mandatory pre‑test genetic counselling and expert interpretation.
| Feature | Our Test (WASHC5 NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS), full gene analysis | Sanger sequencing, limited to known hotspot mutations |
| Diagnostic Sensitivity | 99.9% for all variant types | ≥95% for point mutations; may miss large deletions |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Genetic Counselling | Mandatory pre‑test counselling included | Often not included |
| UAE DHA Compliance | Full DHA & MOHAP compliance | Varies by provider |
Physician Insight & Safety Protocols
“A positive WASHC5 variant requires careful clinical correlation with neurological examination and family history. This test provides decisive molecular confirmation, but it is not a substitute for a comprehensive neurology consultation. I encourage all patients to discuss the results with a neurologist or clinical geneticist before making any health decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication or alter your treatment plan without first consulting your treating physician. This test is for diagnostic and counselling purposes only; it does not provide immediate therapeutic recommendations.
Exclusion Criteria & Emergency Red Flags
- This test is not appropriate for acute neurological emergencies (e.g., sudden loss of consciousness, acute stroke symptoms).
- If you experience sudden worsening of leg weakness, loss of bladder or bowel control, or new vision changes, seek immediate emergency care.
- Genetic testing of minors requires strict adherence to Federal Decree-Law No. 4 of 2016 on Medical Liability and mandatory genetic counselling.
Patient FAQ & Clinical Guidance
1. How accurate is the WASHC5 NGS test for diagnosing hereditary spastic paraplegia SPG8?
Answer: Our next‑generation sequencing delivers over 99.9% analytical sensitivity and specificity for all clinically relevant WASHC5 variants, making it the most definitive molecular diagnostic tool available in the UAE today. Combined with mandatory genetic counselling, the result can confirm SPG8 with near‑certainty, enabling precise family planning and tailored neurological care.
2. What sample is required, and is home collection available?
Answer: We accept whole blood, extracted DNA, or FTA card samples collected by our VIP mobile phlebotomy team between 8 AM and 11 PM. Home collection is included in the service. For insurance billing, message us on WhatsApp at +971 54 548 8731 for instant verification and scheduling.
3. Does the price include genetic counselling, and what is the turnaround time?
Answer: Yes, the 2,800 AED fee includes a mandatory pre‑test genetic counselling session with a qualified consultant. The final report is issued within 3–4 weeks and includes expert interpretation.
4. Are my genetic data protected under UAE law?
Answer: Absolutely. All personal health information and genomic data are handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your results are never shared without explicit consent.
UAE Regulatory & Data Privacy Adherence
ISO 9001:2015 Certified Medical Testing (Cert: INT/EGQ/2509DA/3139)
This laboratory adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 for health information security. Patient data is encrypted, access‑controlled, and never shared without consent.
Clinical & Logistical Metadata
| Test Name | WASHC5 Gene (SPG8) Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card (Peripheral Blood) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Analysis |
| ICD-10-CM Code | G11.4 (Hereditary Spastic Paraplegia) |
| LOINC Code | 81246-7 (Gene full sequencing in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians